4.6 Article

Hepatocellular Carcinoma in Olmsted County, Minnesota, 1976-2008

Journal

MAYO CLINIC PROCEEDINGS
Volume 87, Issue 1, Pages 9-16

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.mayocp.2011.07.001

Keywords

-

Funding

  1. National Institute of Diabetes and Digestive and Kidney Diseases [DK84832, DK34238]
  2. National Institute on Aging [R01 AG034676]
  3. National Center for Research Resources [RR024150]
  4. National Institutes of Health
  5. Bristol Myers Squibb
  6. MDS Nordion

Ask authors/readers for more resources

Objective: To analyze longitudinal trends in the incidence, etiology, and treatment of hepatocellular carcinoma (HCC) in community residents in Olmsted County, Minnesota, and their survival. Patients and Methods: Olmsted County residents 20 years or older with HCC newly diagnosed from January 1, 1976, through December 31, 2008, were identified using a community-wide medical record linkage system (Rochester Epidemiology Project). The incidence rate of HCC was calculated by age and sex according to the 2000 US Census population. Temporal trends of HCC etiology, treatment, and patient survival were assessed. Results: The age- and sex-adjusted incidence rate for HCC in Olmsted County was 3.5 per 100,000 person-years for the first era (1976-1990), 3.8 per 100,000 for the second era (1991-2000), and 6.9 per 100,000 for the third era (2001-2008). Alcohol use was the most common risk factor in the first and second eras and chronic hepatitis C virus in the third. The proportion attributed to nonalcoholic fatty liver disease was small (5/47 [10.6%] in the third era). Because the proportion of patients receiving curative treatment increased over time, survival also improved, with a median survival time of 3, 6, and 9 months in the first, second, and third eras, respectively (P=.01). Conclusion: In this midwestern US community, the incidence of HCC has increased, primarily due to hepatitis C virus. Although there was a demonstrable improvement in the outcome of HCC in community residents over time, the overall prognosis remains poor. (C) 2012 Mayo Foundation for Medical Education and Research Mayo Clin Proc. 2012:87(1)9-16

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available